VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar emptygestures (< 20) Submitted: 12/14/2010 3:00:17 PM : Underperform Start Price: $9.30 VVUS Score: -158.63

OREX will beat them to it.

Featured Broker Partners


Advertisement